{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:50:18Z","timestamp":1777341018129,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04298-3","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:54:28Z","timestamp":1773287668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel LUC7L::NUTM1 fusion in PDGFRA-rearranged myeloproliferative neoplasm with eosinophilia: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanbing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"7","key":"4298_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"issue":"5","key":"4298_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.27287","volume":"99","author":"W Shomali","year":"2024","unstructured":"Shomali W, Gotlib J. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024;99(5):946\u201368.","journal-title":"Am J Hematol"},{"key":"4298_CR3","doi-asserted-by":"publisher","first-page":"734025","DOI":"10.3389\/fonc.2021.734025","volume":"11","author":"M Scium\u00e8","year":"2021","unstructured":"Scium\u00e8 M, Ceparano G, Eller-Vainicher C, Fabris S, Lonati S, Croci GA, et al. Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib. Front Oncol. 2021;11:734025.","journal-title":"Front Oncol"},{"issue":"21","key":"4298_CR4","first-page":"1188","volume":"150","author":"MC Verstappen","year":"2006","unstructured":"Verstappen MC, Mattijssen V, van der Reijden BA, van der Heijden AJ, Wahab PJ, de Vries RA. [A man with oral ulcers caused by hypereosinophilic syndrome and a good response to the tyrosine-kinase inhibitor imatinib]. Ned Tijdschr Geneeskd. 2006;150(21):1188\u201392.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"9","key":"4298_CR5","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","volume":"102","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM, et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood. 2003;102(9):3093\u20136.","journal-title":"Blood"},{"issue":"4","key":"4298_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/sj.leu.2403313","volume":"18","author":"P Vandenberghe","year":"2004","unstructured":"Vandenberghe P, Wlodarska I, Michaux L, Zach\u00e9e P, Boogaerts M, Vanstraelen D, et al. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia. 2004;18(4):734\u201342.","journal-title":"Leukemia"},{"issue":"12","key":"4298_CR7","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","volume":"101","author":"AD Klion","year":"2003","unstructured":"Klion AD, Noel P, Akin C, Law MA, Gilliland DG, Cools J, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood. 2003;101(12):4660\u20136.","journal-title":"Blood"},{"issue":"1","key":"4298_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.revmed.2007.09.036","volume":"29","author":"S Menif","year":"2008","unstructured":"Menif S, Ben Romdhane N, Hafsia R. [Efficacy of imatinib in FIP1L1-PDGFRA positive hypereosinophilic syndrome]. Rev Med Interne. 2008;29(1):65\u20137.","journal-title":"Rev Med Interne"},{"issue":"8","key":"4298_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.leukres.2005.11.011","volume":"30","author":"A Pardanani","year":"2006","unstructured":"Pardanani A, Ketterling RP, Li CY, Patnaik MM, Wolanskyj AP, Elliott MA, et al. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk Res. 2006;30(8):965\u201370.","journal-title":"Leuk Res"},{"issue":"6","key":"4298_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1600-0609.2006.00652.x","volume":"76","author":"G Helbig","year":"2006","unstructured":"Helbig G, Stella-Holowiecka B, Grosicki S, Bober G, Krawczyk M, Wojnar J, et al. The results of imatinib therapy for patients with primary eosinophilic disorders. Eur J Haematol. 2006;76(6):535\u20136.","journal-title":"Eur J Haematol"},{"issue":"20","key":"4298_CR11","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"issue":"10","key":"4298_CR12","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/head.12246","volume":"53","author":"JJ Gagnier","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013;53(10):1541\u20137.","journal-title":"Headache"},{"issue":"3","key":"4298_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/ajcp\/aqaa056","volume":"154","author":"DM Mattis","year":"2020","unstructured":"Mattis DM, Wang SA, Lu CM. Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia. Am J Clin Pathol. 2020;154(3):305\u201318.","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"4298_CR14","first-page":"779","volume":"41","author":"XS Fan","year":"2012","unstructured":"Fan XS, Wang SA. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1]. Zhonghua Bing Li Xue Za Zhi. 2012;41(11):779\u201383.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"2","key":"4298_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/ajcp\/aqaa208","volume":"155","author":"O Pozdnyakova","year":"2021","unstructured":"Pozdnyakova O, Orazi A, Kelemen K, King R, Reichard KK, Craig FE, et al. Myeloid\/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. Am J Clin Pathol. 2021;155(2):160\u201378.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"4298_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.iac.2007.07.008","volume":"27","author":"TB Nutman","year":"2007","unstructured":"Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007;27(3):529\u201349.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"4298_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1708-8305.2006.00045.x","volume":"13","author":"SR Caruana","year":"2006","unstructured":"Caruana SR, Kelly HA, Ngeow JY, Ryan NJ, Bennett CM, Chea L, et al. Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia. J Travel Med. 2006;13(4):233\u20139.","journal-title":"J Travel Med"},{"issue":"1","key":"4298_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/jcrt.JCRT_940_19","volume":"18","author":"P Sharma","year":"2022","unstructured":"Sharma P, Khaire NS, Sreedharanunni S, Malhotra P, Varma N. Likely to be missed if unsuspected: FIP1L1-PDGFRA positive myeloid neoplasm in a patient with nodal T-lineage lymphoblastic lymphoma. J Cancer Res Ther. 2022;18(1):316\u20137.","journal-title":"J Cancer Res Ther"},{"issue":"9","key":"4298_CR19","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1172\/JCI126185","volume":"129","author":"S Sekine","year":"2019","unstructured":"Sekine S, Kiyono T, Ryo E, Ogawa R, Wakai S, Ichikawa H, et al. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J Clin Invest. 2019;129(9):3827\u201332.","journal-title":"J Clin Invest"},{"issue":"1","key":"4298_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/cup.13832","volume":"48","author":"O Parra","year":"2021","unstructured":"Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility. J Cutan Pathol. 2021;48(1):95\u2013101.","journal-title":"J Cutan Pathol"},{"issue":"7","key":"4298_CR21","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00277-020-04000-x","volume":"99","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, Luo Y, Zhang Y, Wang Y, Chen Y, Xu Y, et al. A novel NAP1L4\/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction. Ann Hematol. 2020;99(7):1561\u20134.","journal-title":"Ann Hematol"},{"issue":"6","key":"4298_CR22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41379-019-0206-z","volume":"32","author":"TM Stevens","year":"2019","unstructured":"Stevens TM, Morlote D, Xiu J, Swensen J, Brandwein-Weber M, Miettinen MM, et al. NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Mod Pathol. 2019;32(6):764\u201373.","journal-title":"Mod Pathol"},{"issue":"6","key":"4298_CR23","first-page":"1138","volume":"12","author":"MS Springer","year":"1995","unstructured":"Springer MS, Hollar LJ, Burk A. Compensatory substitutions and the evolution of the mitochondrial 12S rRNA gene in mammals. Mol Biol Evol. 1995;12(6):1138\u201350.","journal-title":"Mol Biol Evol"},{"issue":"7","key":"4298_CR24","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol. 2021;38(7):3022\u20137.","journal-title":"Mol Biol Evol"},{"issue":"W1","key":"4298_CR25","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkz357","volume":"47","author":"B Subramanian","year":"2019","unstructured":"Subramanian B, Gao S, Lercher MJ, Hu S, Chen WH. Evolview v3: a webserver for visualization, annotation, and management of phylogenetic trees. Nucleic Acids Res. 2019;47(W1):W270\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4298_CR26","doi-asserted-by":"publisher","first-page":"W236","DOI":"10.1093\/nar\/gkw370","volume":"44","author":"Z He","year":"2016","unstructured":"He Z, Zhang H, Gao S, Lercher MJ, Chen WH, Hu S. Evolview v2: an online visualization and management tool for customized and annotated phylogenetic trees. Nucleic Acids Res. 2016;44(W1):W236\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"(Web Server iss","key":"4298_CR27","doi-asserted-by":"publisher","first-page":"W569","DOI":"10.1093\/nar\/gks576","volume":"40","author":"H Zhang","year":"2012","unstructured":"Zhang H, Gao S, Lercher MJ, Hu S, Chen WH. EvolView, an online tool for visualizing, annotating and managing phylogenetic trees. Nucleic Acids Res. 2012;40(Web Server issue):W569\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4298_CR28","doi-asserted-by":"publisher","first-page":"W276","DOI":"10.1093\/nar\/gkac240","volume":"50","author":"F Madeira","year":"2022","unstructured":"Madeira F, Pearce M, Tivey ARN, Basutkar P, Lee J, Edbali O, et al. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res. 2022;50(W1):W276\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"4298_CR29","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1101\/gr.849004","volume":"14","author":"GE Crooks","year":"2004","unstructured":"Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004;14(6):1188\u201390.","journal-title":"Genome Res"},{"issue":"20","key":"4298_CR30","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1093\/nar\/18.20.6097","volume":"18","author":"TD Schneider","year":"1990","unstructured":"Schneider TD, Stephens RM. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 1990;18(20):6097\u2013100.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4298_CR31","doi-asserted-by":"publisher","first-page":"108989","DOI":"10.1016\/j.celrep.2021.108989","volume":"35","author":"NJ Daniels","year":"2021","unstructured":"Daniels NJ, Hershberger CE, Gu X, Schueger C, DiPasquale WM, Brick J, et al. Functional analyses of human LUC7-like proteins involved in splicing regulation and myeloid neoplasms. Cell Rep. 2021;35(2):108989.","journal-title":"Cell Rep"},{"issue":"9","key":"4298_CR32","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.molcel.2021.02.033","volume":"81","author":"AA Jourdain","year":"2021","unstructured":"Jourdain AA, Begg BE, Mick E, Shah H, Calvo SE, Skinner OS, et al. Loss of LUC7L2 and U1 snRNP subunits shifts energy metabolism from glycolysis to OXPHOS. Mol Cell. 2021;81(9):1905. 19.e12.","journal-title":"Mol Cell"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04298-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:22:58Z","timestamp":1777339378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04298-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4298"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04298-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Xi\u2019an International Medical Center Hospital (No. 777, Xitai Road, High-tech Zone, Xi\u2019an City, Shaanxi Province) and the Declaration of Helsinki was followed (Number: GJYX-KY-2023-087, Date:2023-4-30).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The publication of this study has been approved by the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}